Publication date: 17 September 2026 Source: Molecular Therapy Oncology, Volume 34, Issue 3 Author(s): Leslie Elsner, Maxim Girod, Ahmet Hazini, Anja Geisler, Lisanne Heimann, Babette Dieringer, Jackson Shipman-Mueller, Andreas Thiel, Robert Klopfleisch, Jens Kurreck, Sophie Van Linthout, Henry Fechner
Arming oncolytic Coxsackievirus B3 with Neoleukin-2/15 enhances growth inhibition of colorectal carcinomas and induces T cell activation. // Molecular Therapy: Oncology. – URL: https://www.sciencedirect.com/science/article/pii/S2950329926001682?dgcid=rss_sd_all
Arming oncolytic Coxsackievirus B3 with Neoleukin-2/15 enhances growth inhibition of colorectal carcinomas and induces T cell activation. Molecular Therapy: Oncology. https://www.sciencedirect.com/science/article/pii/S2950329926001682?dgcid=rss_sd_all
“Arming oncolytic Coxsackievirus B3 with Neoleukin-2/15 enhances growth inhibition of colorectal carcinomas and induces T cell activation.” Molecular Therapy: Oncology.
@article{article108284,
title = {Arming oncolytic Coxsackievirus B3 with Neoleukin-2/15 enhances growth inhibition of colorectal carcinomas and induces T cell activation},
journal = {Molecular Therapy: Oncology},
url = {https://www.sciencedirect.com/science/article/pii/S2950329926001682?dgcid=rss_sd_all}
}